Abstract
This commentary focuses on the promise of more effective and less toxic treatments for children with cancer in the age of targeted therapy, as well as the challenges still to be overcome to best inform pediatric drug development.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
